Norion Anticancer Drug Design
SHORT CODE
NADD2
MODEL
Continuous publication
STATUS
Open for submissions
Aims and scope
Original research and reviews in anticancer drug design. Norion Anticancer Drug Design publishes continuously: accepted articles appear the day of acceptance, each with its own article number in the year's rolling volume. Every submission is peer reviewed, and every decision rests with the journal's editors.